More on TXG
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $72.39 |
|
|||
| Open | $71.91 | ||||
| 52 Wk High | $0.00 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $73.99 | ||||
| Day Low | $67.52 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 3,387,155 | ||||
- 10x Genomics to Report Third Quarter 2026 Financial Results on November 5, 2026
- 10X Genomics (TXG) PT Raised to $70 at TD Cowen
- 10X Genomics (TXG) PT Raised to $70 at Morgan Stanley
- 10X Genomics (TXG) PT Raised to $100 at Canaccord
- Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: ARK Investment Management LLC
- 10x Genomics partners with Fred Hutch on cancer research projects
- 10x Genomics Announces New Collaboration to Advance Single Cell and Spatial Applications Across Solid Tumors and Blood Cancers
- 10X Genomics (TXG) PT Raised to $110 at Barclays
- Torex Gold Reports Q3 2026 Production Results
- 10x Genomics begins global shipments of Atera spatial biology platform
Entities mentioned with TXG
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Twitter | View Related Stories »
- 13G | View Related Stories »
- Visium Asset Management | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
